LEDERMAN SETH 4/A
4/A · Tonix Pharmaceuticals Holding Corp. · Filed Mar 6, 2024
Insider Transaction Report
Form 4/AAmended
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2024-02-27+1,903,680→ 1,903,680 totalExercise: $0.46From: 2025-02-27Exp: 2034-02-27→ Common Stock (1,903,680 underlying) - Award
Stock Option
2024-02-27+235,320→ 235,320 totalExercise: $0.37From: 2025-02-27Exp: 2034-02-27→ Common Stock (235,320 underlying) - Award
Stock Option
2024-02-27+1,309,911→ 1,309,911 totalExercise: $0.37From: 2024-08-27Exp: 2034-02-27→ Common Stock (1,309,911 underlying)
Footnotes (3)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
- [F3]The amendment corrects the Conversion or Exercise Price of from $0.0368 to $0.368.